APM
RVMD icon

a16z Perennial Management’s Revolution Medicines RVMD Stock Holding History

a16z Perennial Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.64M Sell
51,490
-52,724
-51% -$7.7M 0.78% 20
2026
Q1 		$10.1M Sell
104,214
-78,704
-43% -$7.95M 0.84% 17
2025
Q4 		$14.6M Buy
+182,918
New +$12M 1.09% 16
2025
Q3 		– Sell
-1,823
Closed -$67.1K – 156
2025
Q2 		$67.1K Buy
+1,823
New +$70K 0.01% 35

Other funds holding RVMD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

a16z Perennial Management's RVMD Position: Q2 2026 in Review

a16z Perennial Management reduced its Revolution Medicines (RVMD) stake by 51% in Q2 2026, selling an estimated $7.7M and leaving 51,490 shares worth $9.64M. The position accounts for 0.78% of the portfolio, ranked #20.

a16z Perennial Management first reported a position in RVMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.6M in Q4 2025. 199 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • a16z Perennial Management held 51,490 shares of Revolution Medicines worth $9.64M as of Q2 2026.
  • a16z Perennial Management sold 52,724 Revolution Medicines shares in Q2 2026, an estimated $7.7M.
  • Revolution Medicines made up 0.78% of a16z Perennial Management's portfolio in Q2 2026, its #20 holding.
  • a16z Perennial Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 4 quarters since.
  • a16z Perennial Management's Revolution Medicines position peaked at $14.6M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on a16z Perennial Management's 13F filing for Q2 2026, filed 24 Jul 2026.